Maia biotechnology (nyse: maia) has received fda orphan drug designation for thio as a treatment for most aggressive brain cancer

Chicago, il / accesswire / november 17, 2023 / more than 300,000 people are diagnosed with brain cancer across the globe each year. glioblastoma represents the majority of these cases in the u.s., with 15,000 new patients diagnosed and more than 10,000 deaths annually.
MAIA Ratings Summary
MAIA Quant Ranking